Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cryocompression for CIPN
Sponsor: Dana-Farber Cancer Institute
Summary
This study aims to evaluate the effectiveness, tolerability, and safety of using cooling therapy and pressure (cryocompression) to reduce peripheral neuropathy, a condition affecting the nerves supplying the arms and legs (limbs) resulting in possible numbness, pain, and/or loss of motor function, that may occur as a result of taxane-based chemotherapy. The name of the device used in this research study is: -Paxman Limb Cryocompression System (PLCS)
Official title: Evaluating the Use of Limb Cryocompression to Reduce Taxane-induced Peripheral Neuropathy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-10-22
Completion Date
2027-08
Last Updated
2025-11-18
Healthy Volunteers
No
Conditions
Interventions
Paxman Limb Cryocompression System
An investigational device designed to provide controlled cooling and compression to participant limbs during chemotherapy administration. The device is comprised of a control unit, connecting hose, and two limb wraps. The customizable limb wraps delivers continuous-flow cooling-and-compression to participant extremities
Locations (1)
Dana-Farber Cancer Institute
Boston, Massachusetts, United States